Next Article in Journal
Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19
Previous Article in Journal
COVID-19 Pandemic: Public Health Risk Assessment and Risk Mitigation Strategies
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 11
Issue 12
10.3390/jpm11121244
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Analgesia Effect of Verum and Sham Acupuncture Treatments in Primary Dysmenorrhea: A MRI Pilot Study

by
Shin-Lei Peng
1,*,
Hui-Chieh Yang
1,
Yu-Chen Lee
2,
Chun-Ming Chen
3,
Ying-Yu Chen
4 and
Cheng-Hao Tu
5,*
1
Department of Biomedical Imaging and Radiological Science, China Medical University, Taichung 404332, Taiwan
2
Department of Acupuncture, China Medical University Hospital, Taichung 404333, Taiwan
3
Department of Medical Imaging, China Medical University Hospital, Taichung 404333, Taiwan
4
Department of Chinese Medicine Gynecology, China Medical University Hospital, Taichung 404333, Taiwan
5
Graduate Institute of Acupuncture Science, China Medical University, Taichung 404332, Taiwan
*
Authors to whom correspondence should be addressed.
J. Pers. Med. 2021, 11(12), 1244; https://doi.org/10.3390/jpm11121244
Submission received: 27 September 2021 / Revised: 19 November 2021 / Accepted: 22 November 2021 / Published: 23 November 2021
Browse Figures
Versions Notes

Abstract

:
Acupuncture is an alternative treatment for primary dysmenorrhea (PDM). However, mechanisms by which acupuncture exerts its analgesic properties are still unclear. This study aimed to explore the cerebral blood flow (CBF) response to verum and sham acupuncture treatments, and further investigate whether pre-treatment CBF is capable of assessing symptom changes after interventions. A total of 11 PDM patients in the verum group and 12 patients in the sham group participated in this study. Pain rating index (PRI), CBF, and gonadal hormone levels were acquired before and after 8-week treatments. Both verum and sham acupuncture treatments exert its analgesic effect on PDM after intervention as PRI reduced (p < 0.05). Blood gonadal levels were not significantly different after acupuncture in both groups (all p > 0.05). In the verum group, intervention-related decreases in CBF were observed in the right dorsal anterior cingulate cortex. In the sham group, regions identified as showing reductions in CBF after acupuncture included the left ventromedial prefrontal cortex, left caudate, and left insula. Patients with higher baseline CBF in the left precuneus and right hippocampus were accompanied with worse treatment response to acupuncture intervention. Mechanisms of verum and sham acupuncture treatments are dissimilar as manifested by different brain responses.

1. Introduction

Primary dysmenorrhea (PDM), the most common gynecological disease, is the occurrence of painful menstrual cramping of the uterus, affecting as many as 85% of women. In addition, PDM also increases the risk of fibromyalgia [1]. Standard treatments for PDM including nonsteroidal anti-inflammatory drugs (NSAIDs) and hormonal contraceptive methods are used to exert hypoalgesic action [2,3]. However, side effects such as gastrointestinal complaint and mild neurological symptoms may deter some females from these medications [4]. Acupuncture is a traditional Chinese medicine procedure that has been considered as an alternative treatment for PDM in East Asia for the past 20 years [5]. The National Institute of Health has also recommended acupuncture as an effective treatment for pain alleviation in PDM [6]. Beneficial effects of acupuncture include increasing participation in daily activities and reducing the amount of ingested pain medication [7]. Moreover, one meta-analysis also suggested that acupuncture-related hypoalgesic effects on PDM were more effective compared with NSAIDs [8].
Acupuncture has garnered increased popularity in pain management [9,10]; however, the mechanisms by which acupuncture exerts its analgesic properties are still unclear. Recent research surmised that acupuncture-related hypoalgesic effects may be associated with functional and structural resilience changes in the brain by using neuroimaging techniques such as resting-state functional magnetic resonance imaging (fMRI) [9,11] and voxel-based morphometry [12]. However, to date, information related to the antihyperalgesic effect of acupuncture in terms of cerebral hemodynamics is limited, especially in the study of PDM.
Cerebral blood flow (CBF), which the amount of blood supplied to the brain, provides a direct measurement for quantitatively assessing brain physiology. CBF measurement is advantageous because of its tight regulation to meet the brain’s metabolic demands, which is known as neurovascular coupling. As it has no radiation burden and is capable of recording regional information, CBF obtained by arterial spin labeling (ASL) magnetic resonance imaging (MRI) is considered a valuable strategy for assessing the impact of PDM on brain perfusion. Studies conducted by Zhang et al. using the ASL technique have shown that PDM is associated with CBF abnormalities [13,14]. Therefore, information obtained by analyzing CBF from ASL is beneficial for understanding the underlying mechanisms of PDM. Despite its potential, no study has investigated the possible acupuncture mechanisms for pain alleviation in PDM through ASL.
Previous studies suggested that the treatment effect of acupuncture is also associated with non-specific factors such as expectancy and degrees of efficacy, depending on the participant’s perceptions and expectations [15,16]. Therefore, comparison of sham acupuncture methods is a critical step toward a better understanding of the efficacy and therapeutic mechanisms of acupuncture [9,11,17]. Moreover, as pain is a subjective and personal experience, responses to acupuncture therapies may depend on an individual’s baseline characteristics. Early studies elucidated the functional connectivity circuits at baseline that could be used to evaluate acupuncture treatment response for patients with PDM [9] and chronic low back pain [11]. In light of these studies, a pertinent question arises as to whether analgesic responses in patients with PDM could be explained by the baseline cerebral hemodynamic differences among individuals. The baseline neuroimaging biomarker can shed more light on the PDM mechanism and, to some extent, determine an optimal therapeutic strategy.
Given that the brain perfusion response to acupuncture treatment is missing in the existing literature, the central goal of this study was to explore the CBF response to both verum and sham acupuncture treatments by using the ASL technique in a longitudinal setting. In addition, whether treatment outcomes could be affected by an individual’s baseline characteristics was further investigated. The findings of this study provide a supplementary understanding of the effects of acupuncture on analgesic actions in PDM.

2. Materials and Methods

2.1. Participants

In this study, 25 right-handed female patients with PDM were recruited through advertisements. The protocol was approved by the local institutional review board, and all participants provided written consent after they were clearly informed of the study protocol. Inclusion criteria for patients with PDM were as follows: (1) age in the range 20–30 years old; (2) regular menstrual cycle of 27–32 days; and (3) average menstrual pain level (including cramping, swelling, tingling, etc.) in the last 6 months rated higher than 4 points on a 10-point visual analog scale (0 = not at all and 10 = the worst pain sensation). The exclusion criteria were as follows: (1) organic pelvic or reproductive system disease(s) found in gynecological ultrasonography; (2) a history of psychiatric or neurologic disorders; (3) current pregnancy or plans for pregnancy; (4) use of oral contraceptives, Chinese herbal medicine, or acupuncture treatment in the past 6 months; and (5) any contraindication for MRI scanning. All patients were required to abstain from any analgesic drugs for at least 24 h prior to the MRI scans.

2.2. Experimental Design

Patients were randomly assigned to either verum or sham acupuncture group using a computer-generated list of random numbers. All patients were blinded to the treatment groups, and only the acupuncturist and staffs knew the treatment strategies. To verify the effectiveness of the single blinding procedure, patients were asked whether they had been treated with verum or sham acupuncture after they completed the intervention. All patients believed that they were treated with verum acupuncture.
The ASL was performed before and after acupuncture intervention. MRI scans were performed during a fixed phase of the follicular phase (Days 5–12 of the menstrual cycle) to preclude the influence of the menstrual phase on CBF measurements. The latest menstrual pain experience was assessed using the Chinese version of the McGill Pain Questionnaire (MPQ) [18] following each MRI scan. The score obtained by summing the intensity values for each of the four categories (sensory, affective, evaluative, and miscellaneous) was defined as the pain rating index (PRI). Venous blood samples were taken to assess the concentrations of estrogen, progesterone, and testosterone within 2 days before or after MRI scans using the chemiluminescent immunoassay sandwich method.

2.3. Acupuncture Treatment

All acupuncture treatments were performed by a licensed acupuncturist with more than 10 years of experience in Chinese medicinal acupuncture. Each patient received a total of 16 acupuncture sessions within 8 weeks (twice a week), and each acupuncture session lasted approximately 20 min. Acupoints of bilateral Sanyinjiao (SP6), located medially four fingers wide above the ankle, were selected. According to the principles of traditional Chinese medicine, SP6 is the junction point of the liver, spleen, and kidney meridians. By strengthening the spleen and nourishing the liver and kidney, it is believed to be useful for dysmenorrhea relief [19].
The skin of the acupoints was first cleaned with an alcohol swab, and an O-ring was placed on the acupoints and covered with white surgical tape to conceal the penetration depth of the needles. The major difference between verum and sham groups was the “skin penetration.” The verum acupuncture uses the standard acupuncture needles that penetrate the skin of SP6 to a depth of approximately 25 mm, whereas the sham acupuncture was conducted using the Streiberger needles [20] without skin penetration. In both the verum and sham groups, needles were not manipulated during the retention time.

2.4. MRI Acquisition

All experiments were performed on a 3T MR system (Signa HDxt, GE, Wisconsin, USA) using a 16-channel head coil. Foam padding was used to stabilize the head to minimize motion. The MRI protocol consisted of a T1-weighted (T1W) fast spoiled gradient echo (FSPGR) and a pseudo-continuous ASL (pCASL) sequence. The scan parameters of the FSPGR sequence were as follows: repetition time (TR)/echo time (TE)/flip angle (FA) = 8.02 ms/2.99 ms/12°, inversion time (TI) = 450 ms, spatial resolution = 1 × 1 × 1 mm3, and number of slices = 170. Scan parameters of the 2D pCASL sequence were as follows: TR/TE/FA = 4600 ms/9.8 ms/90°, spatial resolution = 2 × 2 × 4 mm3, number of slices = 36, post labeling delay (PLD) = 1.8 s, labeling duration (LD) = 1.5 s, single-shot echo planar imaging, and 30 pairs of label and control images.

2.5. MRI Data Processing

The first step of ASL data analysis was to realign control and label images for motion correction using Statistical Parametric Mapping (SPM) software (https://www.fil.ion.ucl.ac.uk/spm/) running in MATLAB (Mathworks, Natick, MA, USA). Label and control pCASL images were pair-wise subtracted and averaged to obtain perfusion weighted images. The quantification of CBF from the perfusion-weighted images was calculated using a model described previously [21]. All the CBF maps were co-registered to the standard template in Montreal Neurological Institute space. The resulting images were smoothed using an 8 mm full-width-at-half-maximum isotropic Gaussian kernel.

2.6. Statistical Analysis

To ensure no assumption was made about the probability distribution of the dataset, the non-parametric Mann–Whitney U test was performed on the demographic data, total PRI from MPQ, and blood hormone levels to compare the clinical features acquired from the two groups. The non-parametric Wilcoxon rank test was used to determine whether alterations in the aforementioned parameters were significantly different after treatment in each group. P less than 0.05 was considered significantly.
A two-sample t-test from SPM was used to test the region-specific differences in CBF between the groups, with age and gynecologic age as covariates. Here, CBF before and after treatment was tested. A paired t-test was performed for each group to assess voxewise differences in CBF before and after treatment using SPM. Predicted activations were considered significant at p < 0.005 (uncorrected) and clusters of more than 100 voxels. Furthermore, clusters of contiguous voxels classified as significant were extracted as regions of interest (ROIs). The averaged CBF within the ROI was calculated for each subject, and the differences in CBF before and after treatment were compared using the non-parametric Wilcoxon rank test. Less than 0.05 was considered significant. In addition, two treatment groups were combined as a pooled group to investigate whether the acupuncture treatment response could be affected by an individual’s baseline CBF. A general linear model was used with changes in pain severity (pre-treatment-post-treatment) as a dependent variable, and baseline CBF, treatment method, and age were independent variables.

3. Results

3.1. Demographic and Clinical Information

Among the twenty-five participants, one patient dropped out during the intervention session and another was excluded owing to image artifacts, leaving eleven patients in the verum group and twelve patients in the sham group. No significant differences were found in gynecologic age, body mass index, length of menstrual cycle, or dysmenorrhea history (all p > 0.05). Demographic information of the patients is listed in Table 1. The gonadal hormone levels of estrogen, progesterone, and testosterone are shown in Table 2. The blood gonadal concentrations were not significantly different before and after acupuncture interventions in both groups (all p > 0.05), suggesting that acupuncture does not affect hormone levels.
The results of total PRI from MPQ are displayed in Figure 1. In the verum group, the values of total PRI before and after intervention were 29.5 ± 13 and 19.2 ± 13, respectively. In the sham group, the values of total PRI before and after intervention were 32.6 ± 16.7 and 20.6 ± 19.4, respectively. The values of total PRI significantly decreased in both groups (both p < 0.05), suggesting the analgesic effect of both verum and sham acupuncture on PDM after 8 weeks of intervention. The total PRI after intervention was not significantly different between groups (p = 0.73), suggesting that the treatment effect was comparable between groups.

3.2. CBF Voxelwise Analyses

The regional CBF maps measured with ASL MRI were then analyzed to examine which brain regions manifested acupuncture-associated alterations. In the verum group, voxelwise analyses suggested that intervention-related decreases in CBF were most significant in the right dorsal anterior cingulate cortex (dACC) (Figure 2). In the sham group, regions identified with CBF reductions after acupuncture included the left ventromedial prefrontal cortex (vmPFC), left caudate, and left insula (Figure 3). In terms of ROI analysis (Figure 4), CBF in the aforementioned regions decreased significantly after treatment (all p < 0.01). The opposite result, i.e., acupuncture-related increase in CBF, was not detected in either group. The CBF between verum and sham groups did not differ significantly before and after treatments.

3.3. Regression Analysis between Changes in Total PRI and Baseline CBF

To investigate the analgesic relevance following acupuncture, we correlated the pre-post changes in total PRI score with the baseline CBF for the pooled group. After controlling for age and treatment group, the left precuneus and right hippocampus showed a significantly negative correlation between changes in clinical pain and baseline CBF (Figure 5), suggesting that higher baseline CBF in these regions was associated with worse treatment response in patients with PDM.

4. Discussion

This exploratory study investigated the cerebral hemodynamic response to acupuncture treatment in PDM using the neuroimaging biomarker of CBF. Our results show that acupuncture exerting hypoalgesic action might not be mediated by the hormone levels in patients with PDM. Instead, acupuncture might reverse chronification by decreasing CBF to mediate the perception of nociceptive input. Moreover, the mechanisms of verum and sham acupuncture treatments are dissimilar, as manifested by different brain responses. Both verum and sham acupuncture treatments demonstrated a salutary effect on PDM; however, the changes in pain severity depended on the baseline CBF, with patients having higher resting perfusion in the precuneus and hippocampus but minimal response to acupuncture treatment. The findings in this study provide new information on tracking the impact of the antinociceptive characteristics of acupuncture on PDM using the brain perfusion technique.
The reduced CBF observed in the dACC after verum acupuncture treatment is intriguing and warrants further investigation. Verum acupuncture can stimulate the afferent fibers of peripheral nerves and elicit De-Qi sensation [22], and it is believed to achieve its analgesic effect by activating the antinociceptive system, for instance through increased opioid receptor availability [17,23]. A positive correlation between opioid receptor availability and pain alleviation was demonstrated in a previous study [24]. Moreover, opioid receptors are well known to contribute to the vasoconstriction effect, and direct activation of opioid receptors causes sustained decreases in cerebral blood volume (CBV) [25]. Given that the experience of chronic pain is the result of complex neurological processes [26], chronic pain generally activates dACC [27], which has been implicated in circuits involved decision making, emotional processing, learning, and sensory attention [28,29,30,31]. In this regard, decreased CBF in dACC after verum acupuncture intervention could be attributed to the involvement of vasoactive neurotransmitters in this brain region [17] to exert multiple influences on pain relief. This tuning-down effect from verum acupuncture could lead to reappraising the nociceptive memory and reducing aversive prediction, resulting in shifting attention away from incoming pain.
A sham acupuncture strategy is an essential step toward understanding the efficacy and potential therapeutic mechanisms of acupuncture. The procedure of sham acupuncture used in this study provides a sensation on acupoints but does not penetrate the skin, and is indistinguishable from typical verum acupuncture [20,32]. In terms of pain alleviation, sham acupuncture was established to be as effective as verum acupuncture in previous studies [33,34]. The same conclusion was drawn in this study. Given that the peripheral nerves were not stimulated, the significant reductions in CBF found in other pain-associated regions, including the caudate, insula, and vmPFC in response to sham acupuncture may not be generally attributed to a mechanism similar to that of verum acupuncture [17]. The sensory experience of skin stimulation combined with psychological expectation in the belief of acupuncture was suggested to have an important role in shaping placebo analgesia in acupuncture [12,35]. Dopaminergic reward circuitry engages in shaping expectations [36], and recent studies linked increasing dopamine D2/D3 receptor availability in the caudate to placebo hypoalgesia [37]. Moreover, the upregulation of dopamine D2/D3 receptors leads to vasoconstriction [38], thereby causing a notable CBF reduction. In another aspect, the insula is a key region involved in the cognitive modulation of pain and sensory-discriminative components of pain [39]. Neuroimaging studies indicate that reduced pain ratings during placebo analgesia are often coupled with decreased activity in the insula [40,41]. In particular, CBF was shown to tightly correlate with neuronal activity [42]. Thus, results of decreased CBF in the insula in this study may suggest that sham acupuncture exerts its analgesia by inhibiting the neuronal activity in the insula to modulate pain experience. The vmPFC is another brain region linked to cognitive pain modulation, and is also a brain region engaged in expectation-induced analgesia [43]. Increased activation in vmPFC was observed during pain perception [44,45], but interestingly, placebo-induced analgesia is linked to enhanced activity in vmPFC [46], in contrast with the finding of reduced CBF in vmPFC after sham acupuncture intervention in this study. A clear-cut explanation was not obtained for this observation, but possible reasons for this discrepancy may be associated with differences in pain stimulus and treatment strategies.
Verum and sham acupuncture exert hypoalgesic action through different mechanisms, as manifested by different patterns of brain responses; however, our findings also provide some information on shared characteristics evoked by each type of treatments. First, both strategies achieve analgesic effects by decreasing CBF to some extent, thus inhibiting neural activity. Accumulated evidence indicates that patients with PDM present an aberrant increase in neuronal activity. For instance, using resting-state fMRI, Liu et al. found increased spontaneous neural activity in the ACC in patients with PDM versus healthy ones [47]. A study based on positron emission tomography study by Tu et al. showed that patients with PDM increased their cerebral metabolism in the prefrontal regions [48]. Given that acupuncture action involves the interaction between neurotransmitters and modulators, deactivation indicates a redistribution of attention resource [49] and therefore balances pain-related central networks. Second, gonadal hormone levels contribute to the pathogenesis of dysmenorrhea [50], and oral progesterone [2] or estradiol valerate [3] bring immediate relief from symptoms associated with PDM; however, gonadal hormone levels did not change after acupuncture treatments [19] in either group. Based on the results of this study, we tentatively suggest that the analgesic effect of acupuncture might not be mediated by alterations in hormone levels. Instead, direct engagement of brain circuits plays a crucial role in pain chronification.
Although the reduction in pain severity was comparable between verum and sham treatments in this study, existing studies examining the effects of sham acupuncture on PDM have typically produced mixed results [9,19,51]. Three different types of sham acupuncture treatments have been proposed in the literature: (1) using the Streitberger placebo acupuncture needle at the acupoints without skin penetration [11]; (2) using a real acupuncture needle at the acupoints considered specific for another disease [19,51]; and (3) using a real acupuncture needle at the non-acupoints [9,51]. In this study, sham acupuncture treatment was achieved using the Streitberger placebo acupuncture needle at the acupoints without skin penetration. This strategy evoked a similar reduction in pain when compared with verum acupuncture, and the treatment efficiency of Streitberger placebo acupuncture has also been established in other studies [11]. This raises a fundamental question regarding whether acupuncture needles must be inserted at specific acupoints to have their greatest effects [51]. Moreover, as the Streitberger needle causes a pricking sensation, it might not be completely inactive [52]. Collectively, debates on sham acupuncture treatments in PDM are ongoing and welcomed. As we are only at an early stage in our attempt to understand the mechanisms behind the acupuncture treatments by using neuroimaging techniques, comparing with other sham acupuncture treatments such as different acupoints would help to better understand these questions.
The experience of pain-related sensation is derived from the complicated evolution of afferent information arising from peripheral sensory receptors to pain-related brain regions for signal processing. Consequently, treatment outcomes have been proposed to be affected by an individual’s baseline characteristics. Indeed, our results demonstrated that a higher baseline CBF in the precuneus and hippocampus was associated with a worse treatment response in patients with PDM. Both the precuneus and hippocampus are the key nodes of the default mode network (DMN), and recent studies suggested that hypertrophic alterations of the precuneus and hippocampus may be intricately involved in the pathophysiology of PDM. Relative to normal participants, patients with PDM showed an aberrant increase in resting CBF and gray matter volume in the precuneus [13] and hippocampus [53], respectively. Moreover, patients with PDM displayed enhanced precuneus [47] and hippocampus [54] spontaneous neural activity as measured by resting-state fMRI. The DMN plays a significant role in memory consolidation and is the primary network affected by chronic pain [55]. Chronic pain has been conceptualized as a type of learning behavior [56]. If long-term accumulation of nociceptive memory of PDM has disrupted the dynamics of brain plasticity in precuneus and hippocampus due to the hypertrophic alterations, no nociceptive memory updates, thereby reducing the pain relief response to treatment.
The results of this study must be interpreted in light of some limitations. First, CBF did not differ significantly between groups after treatments, and this could be partially attributed to the relatively small sample size in this study. Future studies with a larger sample size could be an essential step toward a better understanding of brain alterations after acupuncture treatment in patients with PDM. Second, all participants underwent MRI scans after an 8-week treatment. The long-term effect of acupuncture was not explored. Third, the present study only explored the “trait pain” at the follicular phase while symptoms were absent. Given that the PDM is a cyclic chronic pain, scanning participants during the “state pain” at the menstrual period could shed more light on the analgesic effect of acupuncture. The fourth limitation was that no control group was evaluated in this study. As acupuncture treatment requires a significant amount of time and there is no motivation for the control group to receive acupuncture treatments if they have no symptoms, the recruitment of control subjects was a challenge in this study and in other neuroimaging studies [9,10,11,12,17].

5. Conclusions

In conclusion, the data presented in this study showed that both verum and sham acupuncture can exert analgesic effects by decreasing CBF to mediate the perception of nociceptive input in patients with PDM, but mechanisms should be different as manifested by different pattern of brain responses. In addition, a higher baseline CBF in the precuneus and hippocampus were accompanied by a worse acupuncture treatment response. Collectively, findings of this study support the idea that CBF from ASL technique can be considered as a useful neuroimaging biomarker for investigating different brain mechanisms underlying verum and sham acupuncture in patients with PDM.

Author Contributions

S.-L.P. and C.-H.T. wrote the manuscript and obtained funding. S.-L.P., H.-C.Y., Y.-C.L., C.-M.C., Y.-Y.C. and C.-H.T. conducted the experiments and analyzed the data. All authors have read and agreed to the published version of the manuscript.

Funding

The authors thank the financial support from Ministry of Science and Technology, Taiwan (MOST 109-2320-B-039-043, MOST 107-2314-B-039-058-MY2, and MOST 106-2314-B-039-012) and China Medical University, Taiwan (CMU109-S-43, CMU108-MF-03, and CMU107-N-24).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Institutional Review Board of China Medical University Hospital, Taiwan (CMUH105-REC1-027).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data can be freely given upon request.

Acknowledgments

The authors thank the participants of the study and the technical support from Medical Research Core Facility, Office of Research and Development at China Medical University, Taiwan.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Tu, C.-H.; Lin, C.-L.; Yang, S.-T.; Shen, W.-C.; Chen, Y.-H. Hormonal Contraceptive Treatment May Reduce the Risk of Fibromyalgia in Women with Dysmenorrhea: A Cohort Study. J. Pers. Med. 2020, 10, 280. [Google Scholar] [CrossRef] [PubMed]
  2. Bernardi, M.; Lazzeri, L.; Perelli, F.; Reis, F.M.; Petraglia, F. Dysmenorrhea and related disorders. F1000Research 2017, 6, 1645. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Petraglia, F.; Parke, S.; Serrani, M.; Mellinger, U.; Römer, T. Estradiol valerate plus dienogest versus ethinylestradiol plus levonorgestrel for the treatment of primary dysmenorrhea. Int. J. Gynecol. Obstet. 2014, 125, 270–274. [Google Scholar] [CrossRef] [PubMed]
  4. Marjoribanks, J.; Proctor, M.; Farquhar, C.; Derks, R.S. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst. Rev. 2010, 7, CD001751. [Google Scholar]
  5. Steinberger, A. The Treatment of Dysmenorrhea by Acupuncture. Am. J. Chin. Med. 1981, 9, 57–60. [Google Scholar] [CrossRef]
  6. Campbell, M.A.; McGrath, P.J. Non-pharmacologic Strategies Used by Adolescents for the Management of Menstrual Discomfort. Clin. J. Pain 1999, 15, 313–320. [Google Scholar] [CrossRef]
  7. Chao, M.T.; Wade, C.M.; Abercrombie, P.D.; Gomolak, D. An innovative acupuncture treatment for primary dysmenorrhea: A randomized, crossover pilot study. Altern. Ther. Health Med. 2014, 20, 49–56. [Google Scholar]
  8. Woo, H.L.; Ji, H.R.; Pak, Y.K.; Lee, H.; Heo, S.J.; Lee, J.M.; Park, K.S. The efficacy and safety of acupuncture in women with primary dysmenorrhea: A systematic review and meta-analysis. Medicine 2018, 97, e11007. [Google Scholar] [CrossRef]
  9. Yu, S.; Xie, M.; Liu, S.; Guo, X.; Tian, J.; Wei, W.; Zhang, Q.; Zeng, F.; Liang, F.; Yang, J. Resting-State Functional Connectivity Patterns Predict Acupuncture Treatment Response in Primary Dysmenorrhea. Front. Neurosci. 2020, 14, 559191. [Google Scholar] [CrossRef]
  10. Egorova, N.; Gollub, R.L.; Kong, J. Repeated verum but not placebo acupuncture normalizes connectivity in brain regions dysregulated in chronic pain. NeuroImage Clin. 2015, 9, 430–435. [Google Scholar] [CrossRef] [Green Version]
  11. Tu, Y.; Ortiz, A.; Gollub, R.L.; Cao, J.; Gerber, J.; Lang, C.; Park, J.; Wilson, G.; Shen, W.; Chan, S.-T.; et al. Multivariate resting-state functional connectivity predicts responses to real and sham acupuncture treatment in chronic low back pain. NeuroImage Clin. 2019, 23, 101885. [Google Scholar] [CrossRef]
  12. Liu, J.; Mu, J.; Liu, Q.; Dun, W.; Zhang, M.; Tian, J. Brain structural properties predict psychologically mediated hypoalgesia in an 8-week sham acupuncture treatment for migraine. Hum. Brain Mapp. 2017, 38, 4386–4397. [Google Scholar] [CrossRef] [Green Version]
  13. Zhang, Y.-N.; Huang, Y.-R.; Liu, J.-L.; Zhang, F.-Q.; Zhang, B.-Y.; Wu, J.-C.; Ma, Y.; Xia, J.; Hao, Y.; Huo, J.-W. Aberrant resting-state cerebral blood flow and its connectivity in primary dysmenorrhea on arterial spin labeling MRI. Magn. Reson. Imaging 2020, 73, 84–90. [Google Scholar] [CrossRef]
  14. Zhang, Y.-N.; Huo, J.-W.; Huang, Y.-R.; Hao, Y.; Chen, Z.-Y. Altered amplitude of low-frequency fluctuation and regional cerebral blood flow in females with primary dysmenorrhea: A resting-state fMRI and arterial spin labeling study. J. Pain Res. 2019, 12, 1243–1250. [Google Scholar] [CrossRef] [Green Version]
  15. Hashmi, J.A.; Kong, J.; Spaeth, R.; Khan, S.; Kaptchuk, T.J.; Gollub, R.L. Functional network architecture predicts psychologically mediated analgesia related to treatment in chronic knee pain patients. J. Neurosci. 2014, 34, 3924–3936. [Google Scholar] [CrossRef] [Green Version]
  16. Kong, J.; Kaptchuk, T.J.; Polich, G.; Kirsch, I.; Vangel, M.; Zyloney, C.; Rosen, B.; Gollub, R.L. Expectancy and treatment interactions: A dissociation between acupuncture analgesia and expectancy evoked placebo analgesia. NeuroImage 2009, 45, 940–949. [Google Scholar] [CrossRef] [Green Version]
  17. Harris, R.E.; Zubieta, J.K.; Scott, D.J.; Napadow, V.; Gracely, R.H.; Clauw, D.J. Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on mu-opioid receptors (MORs). NeuroImage 2009, 47, 1077–1085. [Google Scholar] [CrossRef] [Green Version]
  18. Hui, Y.L.; Chen, A.C. Analysis of headache in a Chinese patient population. Ma Zui Xue Za Zhi Anaesthesiol. Sin. 1989, 27, 13–18. [Google Scholar]
  19. Shi, G.-X.; Liu, C.Z.; Zhu, J.; Guan, L.-P.; Wang, D.-J.; Wu, M.-M. Effects of Acupuncture at Sanyinjiao (SP6) on Prostaglandin Levels in Primary Dysmenorrhea Patients. Clin. J. Pain 2011, 27, 258–261. [Google Scholar] [CrossRef]
  20. Streitberger, K.; Kleinhenz, J. Introducing a placebo needle into acupuncture research. Lancet 1998, 352, 364–365. [Google Scholar] [CrossRef]
  21. Peng, S.; Chen, C. The influence of obesity on cerebral blood flow in young adults using arterial spin labeling MRI. NMR Biomed. 2020, 33, 4375. [Google Scholar] [CrossRef] [PubMed]
  22. Hui, K.K.S.; Nixon, E.E.; Vangel, M.G.; Liu, J.; Marina, O.; Napadow, V.; Hodge, S.M.; Rosen, B.R.; Makris, N.; Kennedy, D.N. Characterization of the "deqi" response in acupuncture. BMC Complement. Altern. Med. 2007, 7, 33. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Dougherty, D.D.; Kong, J.; Webb, M.; Bonab, A.A.; Fischman, A.J.; Gollub, R.L. A combined [11C]diprenorphine PET study and fMRI study of acupuncture analgesia. Behav. Brain Res. 2008, 193, 63–68. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Sora, I.; Takahashi, N.; Funada, M.; Ujike, H.; Revay, R.S.; Donovan, D.M.; Miner, L.L.; Uhl, G.R. Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. USA 1997, 94, 1544–1549. [Google Scholar] [CrossRef] [Green Version]
  25. Liu, C.H.; Greve, D.N.; Dai, G.; Marota, J.J.; Mandeville, J.B. Remifentanil administration reveals biphasic phMRI temporal responses in rat consistent with dynamic receptor regulation. NeuroImage 2007, 34, 1042–1053. [Google Scholar] [CrossRef] [Green Version]
  26. Melzack, R.; Coderre, T.J.; Katz, J.; Vaccarino, A. Central Neuroplasticity and Pathological Pain. Ann. N. Y. Acad. Sci. 2006, 933, 157–174. [Google Scholar] [CrossRef]
  27. Russo, J.F.; Sheth, S.A. Deep brain stimulation of the dorsal anterior cingulate cortex for the treatment of chronic neuropathic pain. Neurosurg. Focus 2015, 38, E11. [Google Scholar] [CrossRef]
  28. Bissonette, G.B.; Powell, E.; Roesch, M.R. Neural structures underlying set-shifting: Roles of medial prefrontal cortex and anterior cingulate cortex. Behav. Brain Res. 2013, 250, 91–101. [Google Scholar] [CrossRef] [Green Version]
  29. Devinsky, O.; Morrell, M.J.; Vogt, B.A. Contributions of anterior cingulate cortex to behaviour. Brain 1995, 118, 279–306. [Google Scholar] [CrossRef]
  30. Jahn, A.; Nee, D.E.; Alexander, W.H.; Brown, J.W. Distinct regions of anterior cingulate cortex signal prediction and outcome evaluation. NeuroImage 2014, 95, 80–89. [Google Scholar] [CrossRef] [Green Version]
  31. Rolls, E.T. The cingulate cortex and limbic systems for emotion, action, and memory. Brain Struct. Funct. 2019, 224, 3001–3018. [Google Scholar] [CrossRef] [Green Version]
  32. Kleinhenz, J.; Streitberger, K.; Windeler, J.; Gübacher, A.; Mavridis, G.; Martin, E. Randomised clinical trial comparing the effects of acupuncture and a newly designed placebo needle in rotator cuff tendinitis. Pain 1999, 83, 235–241. [Google Scholar] [CrossRef]
  33. Moffet, H.H. Sham Acupuncture May Be as Efficacious as True Acupuncture: A Systematic Review of Clinical Trials. J. Altern. Complement. Med. 2009, 15, 213–216. [Google Scholar] [CrossRef]
  34. Assefi, N.P.; Sherman, K.J.; Jacobsen, C.; Goldberg, J.; Smith, W.R.; Buchwald, D. A Randomized Clinical Trial of Acupuncture Compared with Sham Acupuncture in Fibromyalgia. Ann. Intern. Med. 2005, 143, 10–19. [Google Scholar] [CrossRef]
  35. Lund, I.; Lundeberg, T. Are Minimal, Superficial Or Sham Acupuncture Procedures Acceptable as Inert Placebo Controls? Acupunct. Med. 2006, 24, 13–15. [Google Scholar] [CrossRef]
  36. Wise, R.A. Dopamine, learning and motivation. Nat. Rev. Neurosci. 2004, 5, 483–494. [Google Scholar] [CrossRef]
  37. Scott, D.J.; Stohler, C.S.; Egnatuk, C.M.; Wang, H.; Koeppe, R.A.; Zubieta, J.-K. Placebo and Nocebo Effects Are Defined by Opposite Opioid and Dopaminergic Responses. Arch. Gen. Psychiatry 2008, 65, 220–231. [Google Scholar] [CrossRef] [Green Version]
  38. Choi, J.-K.; Chen, Y.I.; Hamel, E.; Jenkins, B.G. Brain hemodynamic changes mediated by dopamine receptors: Role of the cerebral microvasculature in dopamine-mediated neurovascular coupling. NeuroImage 2006, 30, 700–712. [Google Scholar] [CrossRef]
  39. Starr, C.J.; Sawaki, L.; Wittenberg, G.; Burdette, J.H.; Oshiro, Y.; Quevedo, A.S.; Coghill, R.C. Roles of the Insular Cortex in the Modulation of Pain: Insights from Brain Lesions. J. Neurosci. 2009, 29, 2684–2694. [Google Scholar] [CrossRef]
  40. Colloca, L.; Klinger, R.; Flor, H.; Bingel, U. Placebo analgesia: Psychological and neurobiological mechanisms. Pain 2013, 154, 511–514. [Google Scholar] [CrossRef] [Green Version]
  41. Zunhammer, M.; Spisák, T.; Wager, T.D.; Bingel, U.; The Placebo Imaging Consortium. Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data. Nat. Commun. 2021, 12, 1–11. [Google Scholar] [CrossRef] [PubMed]
  42. Roy, C.S.; Sherrington, C.S. On the Regulation of the Blood-supply of the Brain. J. Physiol. 1890, 11, 85–158. [Google Scholar] [CrossRef] [PubMed]
  43. Wager, T.D.; Atlas, L.Y. The neuroscience of placebo effects: Connecting context, learning and health. Nat. Rev. Neurosci. 2015, 16, 403–418. [Google Scholar] [CrossRef] [PubMed]
  44. Porro, C.A.; Baraldi, P.; Pagnoni, G.; Serafini, M.; Facchin, P.; Maieron, M.; Nichelli, P. Does Anticipation of Pain Affect Cortical Nociceptive Systems? J. Neurosci. 2002, 22, 3206–3214. [Google Scholar] [CrossRef] [PubMed]
  45. Hsieh, J.-C.; Stone-Elander, S.; Ingvar, M. Anticipatory coping of pain expressed in the human anterior cingulate cortex: A positron emission tomography study. Neurosci. Lett. 1999, 262, 61–64. [Google Scholar] [CrossRef]
  46. Atlas, L.Y.; Wager, T.D. A Meta-analysis of Brain Mechanisms of Placebo Analgesia: Consistent Findings and Unanswered Questions. Mediat. Drugs Gastrointest. Motil. I 2014, 225, 37–69. [Google Scholar] [CrossRef]
  47. Liu, P.; Liu, Y.; Wang, G.; Yang, X.; Jin, L.; Sun, J.; Qin, W. Aberrant default mode network in patients with primary dysmenorrhea: A fMRI study. Brain Imaging Behav. 2016, 11, 1479–1485. [Google Scholar] [CrossRef] [PubMed]
  48. Tu, C.-H.; Niddam, D.M.; Chao, H.-T.; Liu, R.-S.; Hwang, R.-J.; Yeh, T.-C.; Hsieh, J.-C. Abnormal cerebral metabolism during menstrual pain in primary dysmenorrhea. NeuroImage 2009, 47, 28–35. [Google Scholar] [CrossRef]
  49. Huang, Y.; Tang, C.; Wang, S.; Lu, Y.; Shen, W.; Yang, J.; Chen, J.; Lin, R.; Cui, S.; Xiao, H.; et al. Acupuncture regulates the glucose metabolism in cerebral functional regions in chronic stage ischemic stroke patients—a PET-CT cerebral functional imaging study. BMC Neurosci. 2012, 13, 75. [Google Scholar] [CrossRef] [Green Version]
  50. Zahradnik, H.P.; Breckwoldt, M. Contribution to the pathogenesis of dysmenorrhea. Arch. Gynecol. Obstet. 1984, 236, 99–108. [Google Scholar] [CrossRef]
  51. Liu, C.-Z.; Xie, J.-P.; Wang, L.-P.; Zheng, Y.-Y.; Ma, Z.-B.; Yang, H.; Chen, X.; Shi, G.-X.; Li, S.-L.; Zhao, J.-P.; et al. Immediate Analgesia Effect of Single Point Acupuncture in Primary Dysmenorrhea: A Randomized Controlled Trial. Pain Med. 2011, 12, 300–307. [Google Scholar] [CrossRef] [Green Version]
  52. White, P.; Lewith, G.; Hopwood, V.; Prescott, P. The placebo needle, is it a valid and convincing placebo for use in acupuncture trials? A randomised, single-blind, cross-over pilot trial. Pain 2003, 106, 401–409. [Google Scholar] [CrossRef]
  53. Low, I.; Wei, S.-Y.; Lee, P.-S.; Li, W.-C.; Lee, L.-C.; Hsieh, J.-C.; Chen, L.-F. Neuroimaging Studies of Primary Dysmenorrhea. Adv. Exp. Med. Biol. 2018, 1099, 179–199. [Google Scholar] [CrossRef]
  54. Jin, L.; Yang, X.; Liu, P.; Sun, J.; Chen, F.; Xu, Z.; Qin, W.; Tian, J. Dynamic abnormalities of spontaneous brain activity in women with primary dysmenorrhea. J. Pain Res. 2017, 10, 699–707. [Google Scholar] [CrossRef] [Green Version]
  55. Farmer, M.; Baliki, M.N.; Apkarian, A.V. A dynamic network perspective of chronic pain. Neurosci. Lett. 2012, 520, 197–203. [Google Scholar] [CrossRef] [Green Version]
  56. Apkarian, V.A.; Hashmi, J.A.; Baliki, M.N. Pain and the brain: Specificity and plasticity of the brain in clinical chronic pain. Pain 2011, 152, S49–S64. [Google Scholar] [CrossRef]
Jpm 11 01244 g001 550
Figure 1. Total pain rating index from McGill Pain Questionnaire before and after acupuncture treatments. * p < 0.05.
Figure 1. Total pain rating index from McGill Pain Questionnaire before and after acupuncture treatments. * p < 0.05.
Jpm 11 01244 g001
Jpm 11 01244 g002 550
Figure 2. Comparison of cerebral blood flow (CBF) between two time-points in the verum group. Voxelwise analyses demonstrate a decrease in CBF in the right dorsal anterior cingulate cortex after treatment.
Figure 2. Comparison of cerebral blood flow (CBF) between two time-points in the verum group. Voxelwise analyses demonstrate a decrease in CBF in the right dorsal anterior cingulate cortex after treatment.
Jpm 11 01244 g002
Jpm 11 01244 g003 550
Figure 3. Comparison of cerebral blood flow (CBF) between two time-points in the sham group. Voxelwise analyses demonstrate decreases in CBF in the left ventromedial prefrontal cortex, left caudate, and left insula.
Figure 3. Comparison of cerebral blood flow (CBF) between two time-points in the sham group. Voxelwise analyses demonstrate decreases in CBF in the left ventromedial prefrontal cortex, left caudate, and left insula.
Jpm 11 01244 g003
Jpm 11 01244 g004 550
Figure 4. Regions of interest analysis for cerebral blood flow before and after acupuncture treatment. *: p < 0.01.
Figure 4. Regions of interest analysis for cerebral blood flow before and after acupuncture treatment. *: p < 0.01.
Jpm 11 01244 g004
Jpm 11 01244 g005 550
Figure 5. Regression analysis for the relationship between analgesic relevance and baseline cerebral blood flow (CBF). The higher baseline CBF in left precuneus and right hippocampus accompanied with worse treatment response in patients with primary dysmenorrhea.
Figure 5. Regression analysis for the relationship between analgesic relevance and baseline cerebral blood flow (CBF). The higher baseline CBF in left precuneus and right hippocampus accompanied with worse treatment response in patients with primary dysmenorrhea.
Jpm 11 01244 g005
Table
Table 1. The demographic information in both groups. All data are presented as men ± SD.
Table 1. The demographic information in both groups. All data are presented as men ± SD.
Verum (N = 11)Sham (N = 12)p-Value
Age (year)22.55 ± 2.3425.75 ± 4.520.09
Gynecologic age (year)11.36 ± 2.4213.25 ± 5.260.32
Body mass index ((kg/m2)21.94 ± 4.6820.46 ± 1.650.60
Length of menstrual cycle (day)30.36 ± 2.2529.67 ± 2.270.42
Dysmenorrhea history (year)6.73 ± 3.559.92 ± 5.280.09
Table
Table 2. Gonadal hormone levels before and after acupuncture treatments. All data are presented as mean ± standard deviation.
Table 2. Gonadal hormone levels before and after acupuncture treatments. All data are presented as mean ± standard deviation.
VerumSham
PrePostp ValuePrePostp-Value
Estradiol (pg/mL)139.82 ± 110.08141.27 ± 82.920.83138.17 ± 88.89132.75 ± 109.100.91
Progesterone (ng/L)1.59 ± 3.244.09 ± 6.850.411.08 ± 1.302.38 ± 4.510.56
Testosterone (ng/mL)0.61 ± 0.220.60 ± 0.220.950.57 ± 0.110.50 ± 0.140.06
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Peng, S.-L.; Yang, H.-C.; Lee, Y.-C.; Chen, C.-M.; Chen, Y.-Y.; Tu, C.-H. Analgesia Effect of Verum and Sham Acupuncture Treatments in Primary Dysmenorrhea: A MRI Pilot Study. J. Pers. Med. 2021, 11, 1244. https://doi.org/10.3390/jpm11121244

AMA Style

Peng S-L, Yang H-C, Lee Y-C, Chen C-M, Chen Y-Y, Tu C-H. Analgesia Effect of Verum and Sham Acupuncture Treatments in Primary Dysmenorrhea: A MRI Pilot Study. Journal of Personalized Medicine. 2021; 11(12):1244. https://doi.org/10.3390/jpm11121244

Chicago/Turabian Style

Peng, Shin-Lei, Hui-Chieh Yang, Yu-Chen Lee, Chun-Ming Chen, Ying-Yu Chen, and Cheng-Hao Tu. 2021. "Analgesia Effect of Verum and Sham Acupuncture Treatments in Primary Dysmenorrhea: A MRI Pilot Study" Journal of Personalized Medicine 11, no. 12: 1244. https://doi.org/10.3390/jpm11121244

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop